GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Net Investment Income

Heron Therapeutics (STU:AXD2) Net Investment Income


View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics Net Investment Income?

Net Investment Income only applies to insurance companies.


Heron Therapeutics (STU:AXD2) Business Description

Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.